Marcus M. Unger

TL;DR: This study confirms the recently reported association between PD and the abundance of certain gut microbiota and shows a reduction in fecal SCFA concentrations, which might, theoretically, induce alterations in the ENS and contribute to gastrointestinal dysmotility in PD.

TL;DR: The RBD1Q screening question is designed, a screening question for dream enactment with a simple yes/no response foriopathic rapid eye movement sleep behavior disorder.

TL;DR: To assess whether risk factors for Parkinson disease and dementia with Lewy bodies increase rate of defined neurodegenerative disease in idiopathic rapid eye movement (REM) sleep behavior disorder (RBD), a large number of animals were sacrificed for research purposes.

TL;DR: The IRBD-SG provides an important platform for developing multinational collaborative studies on RBD such as on environmental risk factors for iRBD, and on controlled active treatment studies for symptomatic and neuroprotective therapy that emerged during the 2011 consensus conference in Marburg, Germany, as described in this report.

TL;DR: The data indicate that calprotectin, alpha-1-antitrypsin and zonulin could be useful non-invasive markers in PD as well, and corroborate the hypothesis of an intestinal inflammation as contributing factor in the pathogenesis of PD.